UnitedHealth Group posted $447.6 billion in revenue for FY2025 and followed that with $111.7 billion in Q1 2026 alone. The company raised its FY2026 adjusted earnings outlook to more than $18.25 per share after a first quarter that beat Wall Street expectations on both revenue and profit. This post covers UnitedHealth Group’s latest financial results, membership numbers, medical care ratios, Optum segment data, and forward guidance through 2026.
UnitedHealth Group Statistics in 2026 – TL;DR
UnitedHealth Group generated $447.6 billion in FY2025 revenue, up 12% from FY2024’s $400.3 billion.
Q1 2026 consolidated revenue reached $111.7 billion with earnings from operations of $9.0 billion.
The Q1 2026 medical care ratio dropped to 83.9%, down from 84.8% in Q1 2025.
The company now expects FY2026 adjusted EPS of more than $18.25, raised from the initial $17.75 outlook.
UnitedHealth Group’s market capitalization stood at roughly $353 billion as of mid-May 2026, with shares trading near $391.
How Much Revenue Does UnitedHealth Group Generate?
UnitedHealth Group’s full-year 2025 revenue hit $447.6 billion, a 12% jump from $400.3 billion in FY2024. UnitedHealthcare, the insurance arm, brought in $344.9 billion of that total (up 16% year on year), while Optum contributed $270.6 billion (up 7%). Those segment figures exceed the consolidated number because of large intersegment eliminations, mainly from Optum’s services delivered to UnitedHealthcare members.
Q1 2026 continued the growth trend. Consolidated revenue came in at $111.7 billion, compared to $109.6 billion in Q1 2025. UnitedHealthcare Employer & Individual generated $20.1 billion, Medicare & Retirement brought in $42.1 billion (up 1%), and Community & State added $24.1 billion (up 4%).
| Metric | FY2023 | FY2024 | FY2025 | Q1 2026 |
|---|---|---|---|---|
| Total Revenue | ~$371.6B | $400.3B | $447.6B | $111.7B |
| UnitedHealthcare Revenue | ~$281.4B | $298.2B | $344.9B | $86.3B |
| Optum Revenue | ~$226.7B | $253.0B | $270.6B | — |
| YoY Growth (Consolidated) | — | +8% | +12% | +2% |
Source: UnitedHealth Group SEC Form 8-K filings (January 2025, January 2026, April 2026)
What Is UnitedHealth Group’s Medical Care Ratio?
The medical care ratio (MCR) — the share of premium revenue spent on medical claims — climbed from 83.2% in FY2023 to 85.5% in FY2024 and then to 89.1% in FY2025. That 5.9 percentage point increase over two years was the single biggest drag on profitability. Each point of MCR increase erases roughly $4 billion to $4.5 billion in operating income on a $400–$450 billion revenue base.
Q1 2026 brought a reversal. The medical care ratio fell to 83.9%, down from 84.8% in Q1 2025. UnitedHealth Group attributed the improvement to stronger medical cost management and favorable reserve development on previously unprofitable contracts. Elevated utilization and unit cost trends partially offset those gains.
| Period | Medical Care Ratio | Change |
|---|---|---|
| FY2023 | 83.2% | — |
| FY2024 | 85.5% | +2.3pp |
| FY2025 | 89.1% | +3.6pp |
| Q1 2025 | 84.8% | — |
| Q1 2026 | 83.9% | -0.9pp |
Source: UnitedHealth Group SEC Form 8-K filings; Managed Healthcare Executive
UnitedHealth Group Earnings and Profitability
FY2025 was a rough year for earnings. GAAP diluted EPS landed at $13.23, far below the $28.15–$28.65 guidance set at the start of 2025. Adjusted EPS came in at $16.35, missing the $29.50–$30.00 target by about 44%. The net margin for FY2025 was 2.7%, well below UnitedHealth Group’s typical 5–7% range.
Q1 2026 showed recovery. Earnings from operations reached $9.0 billion, net income was $6.28 billion ($6.90 per share), and the net margin recovered to 5.6%. Cash flows from operations were $8.9 billion, or 1.4 times net income.
| Metric | FY2024 | FY2025 | Q1 2026 |
|---|---|---|---|
| Earnings from Operations | $34.4B (adj.) | $19.0B | $9.0B |
| GAAP EPS (diluted) | — | $13.23 | $6.90 |
| Adjusted EPS | — | $16.35 | $7.23 |
| Net Margin | — | 2.7% | 5.6% |
| Operating Cash Flow | $24.2B | $19.7B | $8.9B |
Source: UnitedHealth Group SEC Form 8-K (January 2026, April 2026); CNBC
How Many People Does UnitedHealth Group Serve?
As of December 31, 2024, UnitedHealth Group served 146 million unique individuals across all its businesses. UnitedHealthcare alone covered 49.8 million consumers as of FY2025, while Optum supported more than 123 million people across its health services, pharmacy, and analytics operations.
Within UnitedHealthcare’s insurance lines, domestic commercial enrollment stood at 29.7 million as of year-end 2024, up 2.4 million during the year. Medicare and complex-needs enrollment was 9.4 million, and Medicaid covered 7.4 million members (declining from 7.7 million earlier in 2024 due to eligibility redeterminations). In Q1 2026, the company added 415,000 people in employer-sponsored plans, though it lost 220,000 in Medicaid due to continued state eligibility reviews.
| Membership Category | Figure | Period |
|---|---|---|
| Total Individuals Served | 146 million | Dec 31, 2024 |
| UnitedHealthcare Consumers | 49.8 million | FY2025 |
| Optum Consumers Supported | 123 million+ | FY2025 |
| Domestic Commercial | 29.7 million | Dec 31, 2024 |
| Medicare & Complex Needs | 9.4 million | 2024 |
| Medicaid | 7.4 million | 2024 |
Source: UnitedHealth Group “2024 Results” press release; Form 8-K (January 2026, April 2026)
How Is the Optum Segment Performing?
Optum’s FY2024 revenue was $253 billion, up 12% year on year. Growth was led by Optum Rx (pharmacy services) and Optum Health (care delivery). FY2025 revenue reached $270.6 billion, though growth decelerated to 7%. Optum also added 600,000 patients to its value-based care model in FY2024.
On the cost side, the operating cost ratio improved from 14.7% in FY2023 to 13.2% in FY2024, showing that efficiency gains continued even in a year disrupted by the Change Healthcare cyberattack. That February 2024 incident resulted in $872 million in unfavorable MCR impact in Q1 2024 alone and required more than $6 billion in advance funding and interest-free loans to affected care providers.
UnitedHealth Group FY2026 Outlook and Guidance
UnitedHealth Group initially issued FY2026 guidance in January 2026 calling for revenue above $439.0 billion, adjusted EPS above $17.75, and earnings from operations above $24.0 billion. The revenue figure below FY2025’s $447.6 billion reflected planned portfolio restructuring, including the sale of Optum’s UK business (completed in Q1 2026 for $400 million in net proceeds) and a strategic refocus on U.S. healthcare.
After Q1 2026 results, the company raised its FY2026 adjusted EPS outlook to above $18.25 per share and GAAP EPS outlook to above $17.35. The company also announced the acquisition of Alegeus Technologies (a benefits administration platform), refreshed nearly half its top 100 leadership positions, and authorized at least $2 billion in share repurchases expected by mid-2026.
UnitedHealth Group Market Cap and Stock Performance
UnitedHealth Group traded at roughly $391 per share on the NYSE as of mid-May 2026, putting its market capitalization near $353 billion. The stock’s 52-week range spanned $234.60 to $404.15, reflecting heavy volatility tied to the FY2025 earnings miss and subsequent recovery.
Berkshire Hathaway disclosed in May 2026 that it sold its entire UnitedHealth Group position during Q1 2026. Berkshire had first taken the 5-million-share stake in August 2025 after the stock fell more than 50%. Analysts at Morningstar attributed the exit to leadership changes at Berkshire (Greg Abel replacing Warren Buffett as CEO) rather than a bearish view on UnitedHealth Group’s operational prospects.
| Metric | Value |
|---|---|
| Stock Price (May 19, 2026) | ~$391 |
| Market Capitalization | ~$353 billion |
| 52-Week Low | $234.60 |
| 52-Week High | $404.15 |
| Trailing P/E | 29.5 |
| Dividend Yield | 2.3% |
| CEO | Stephen Hemsley |
Source: Yahoo Finance; UnitedHealth Group Investor Relations (May 2026)
UnitedHealth Group Capital Returns and Shareholder Data
In FY2024, UnitedHealth Group returned over $16 billion to shareholders through dividends and share buybacks. The Q4 2024 return on equity was 23.7%. The company has committed to buying back at least $2 billion of its common stock by end of Q2 2026, funded partly by proceeds from the Optum UK sale.
The FY2024 operating cost ratio of 13.2% (improved from 14.7%) confirmed that UnitedHealth Group squeezed out measurable efficiency gains despite the Change Healthcare disruption. FY2025 cash flows from operations were $19.7 billion (1.5 times net income), down from $24.2 billion in FY2024 (1.6 times net income).
FAQs
What was UnitedHealth Group’s revenue in 2025?
UnitedHealth Group reported $447.6 billion in total consolidated revenue for FY2025, a 12% increase from FY2024’s $400.3 billion.
How many people does UnitedHealth Group serve?
UnitedHealth Group served 146 million unique individuals as of December 31, 2024. UnitedHealthcare covered 49.8 million consumers and Optum supported over 123 million in FY2025.
What is UnitedHealth Group’s medical care ratio in 2026?
The Q1 2026 medical care ratio was 83.9%, an improvement from 84.8% in Q1 2025. The full-year FY2025 MCR was 89.1%.
Who is the CEO of UnitedHealth Group?
Stephen Hemsley became CEO of UnitedHealth Group in 2025, replacing Andrew Witty.
What is UnitedHealth Group’s earnings outlook for 2026?
UnitedHealth Group raised its FY2026 adjusted EPS outlook to more than $18.25 per share after Q1 2026 results, up from the initial guidance of more than $17.75.
Sources:
https://www.cnbc.com/2026/04/21/unitedhealth-group-unh-earnings-q1-2026.html
With many years of professional experience within transnational corporations in different industries, Richard Jaimes has had the opportunity to lead people and organizations, investigate future topics, create strategies and innovations, consult senior management and translate insights into business advantages. Richard is also a long time senior consultant with Quantumrun Foresight.
